SS

Shikha Srivastava

Active Director Director DIN 08588720
DIN 08588720 First appointment Oct 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Shikha Srivastava

Data last updated:

Shikha Srivastava is a Director at Lenore Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Lenore Pharmaceuticals Private Limited reported revenue of ₹1.50 Cr (FY 2024).

DIN 08588720
Primary Designation Director
Industry Trading
First Appointment 16 Oct 2019
Oldest Company Age 7 yrs
Largest company Lenore Pharmaceuticals Private Limited · ₹1.50 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Oct 20192019₹1.50 Cr (FY 2024)Active

Board colleagues of Shikha Srivastava

Directorship timeline

Open interactive timeline →
Lenore Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shikha Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shikha Srivastava

Shikha Srivastava currently holds 1 directorship: Lenore Pharmaceuticals Private Limited (Director, since 16 Oct 2019, revenue ₹1.50 Cr (FY 2024)).

Shikha Srivastava was first appointed on 16 Oct 2019 as Director at Lenore Pharmaceuticals Private Limited.

The current boards of Shikha Srivastava's companies include Poonam Sinha (Lenore Pharmaceuticals Private Limited), Pramod Narain Sinha (Lenore Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available